Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials

MLA

Bernard Combe, et al. “Comparative Efficacy of Subcutaneous (CT-P13) and Intravenous Infliximab in Adult Patients with Rheumatoid Arthritis: A Network Meta-Regression of Individual Patient Data from Two Randomised Trials.” Arthritis Research & Therapy, vol. 23, no. 1, Apr. 2021, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13075-021-02487-x.

APA

Bernard Combe, Yannick Allanore, Rieke Alten, Roberto Caporali, Patrick Durez, Florenzo Iannone, Michael T. Nurmohamed, Mondher Toumi, Sang Joon Lee, Taek Sang Kwon, Jiwon Noh, Gahee Park, & Dae Hyun Yoo. (2021). Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials. Arthritis Research & Therapy, 23(1), 1–11. https://doi.org/10.1186/s13075-021-02487-x

Chicago

Bernard Combe, Yannick Allanore, Rieke Alten, Roberto Caporali, Patrick Durez, Florenzo Iannone, Michael T. Nurmohamed, et al. 2021. “Comparative Efficacy of Subcutaneous (CT-P13) and Intravenous Infliximab in Adult Patients with Rheumatoid Arthritis: A Network Meta-Regression of Individual Patient Data from Two Randomised Trials.” Arthritis Research & Therapy 23 (1): 1–11. doi:10.1186/s13075-021-02487-x.